1. What Is the Single Use Bioreactor Market?
The Single Use Bioreactor Market covers the plastic-bag-based bioreactor systems that use disposable cultivation vessels for mammalian cell culture and microbial fermentation in biopharmaceutical manufacturing, supplied to biopharmaceutical companies, CDMOs, and research institutions. Biopharmaceutical manufacturers use single-use bioreactors to reduce cleaning validation burden, enable faster campaign changeover between products, and lower capital investment per facility compared with traditional stainless-steel systems. The market serves clinical and commercial-scale biologic production, with single-use systems dominating clinical and pilot scale while large commercial bioreactors remain predominantly stainless steel. It includes wave motion rocking bag reactors, stirred-tank single-use systems, and the associated sensors and control hardware, with demand driven by the biologic pipeline and the CDMO capacity expansion cycle.
2. Single Use Bioreactor Market Size & Forecast
3. Emerging Technologies
- Rocking bag wave bioreactors enabling scalable seed train expansion without stirred-tank hydrodynamic stress.
- Large-format stirred-tank single-use bioreactors up to 2000 litres providing commercial capacity in disposable format.
- Single-use sensors for pH, dissolved oxygen, and biomass monitoring within the disposable vessel.
- Parallel small-scale single-use bioreactors enabling high-throughput process development at miniaturised scale.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Cell Culture Media Market.
4. Key Market Opportunity
The largest near-term opportunity in the Single Use Bioreactor market lies in CDMOs building flexible single-use bioreactor suites for multi-client clinical and commercial campaigns. A second, faster-growing opportunity lies in biotech companies selecting single-use for clinical supply with the option of technology transfer to stainless steel at full commercial scale. As adoption broadens, the addressable opportunity is expanding from early deployments toward wider commercial use, with Europe positioned for the most rapid growth through 2034.
5. Top Companies in the Single Use Bioreactor Market
The following organisations hold leading positions in the Single Use Bioreactor Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Cytiva (Danaher)
- Sartorius
- Thermo Fisher Scientific
- Merck KGaA (Millipore Sigma)
- PBS Biotech
- ABEC
- Pall Corporation (Danaher)
- Repligen
- Eppendorf
- Parker Hannifin
6. Market Segmentation
The Single Use Bioreactor Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Type | Wave Rocking Stirred Tank Single-Use Hollow Fibre |
| By Volume | Below 50 Litre 50 to 500 Litre Above 500 Litre |
| By Application | Mammalian Cell Culture Microbial Viral Vector |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Single Use Bioreactor Market trajectory over the forecast period:
Single-Use Bioreactors Have Become the Standard for Clinical-Stage and CDMO Manufacturing.Single-use bioreactors have become the standard for clinical-stage and CDMO manufacturing, as the elimination of steam-in-place cleaning cycles reduces facility downtime between campaigns and removes cleaning validation requirements. This operational advantage is most pronounced in multi-product CDMO facilities that run multiple client campaigns per year. Cytiva's WAVE and Xcellerex systems and Sartorius's Biostat STR are the leading single-use bioreactor platforms. The adoption of single-use at clinical scale has been near-complete in the Western biopharmaceutical industry. The remaining debate is at large commercial scale above 1000 litres where stainless steel remains economically competitive.
Cell Therapy and Gene Therapy Manufacturing Has Adopted Single-Use Almost Exclusively.Cell therapy and gene therapy manufacturing has adopted single-use almost exclusively, as the small batch sizes and stringent product-to-product separation requirements of personalised and allogeneic therapies require frequent changeover and isolated manufacturing environments that single-use provides. Each autologous CAR-T production run is a unique patient-specific batch. Single-use enables patient-specific batch isolation without cross-contamination risk from inadequate cleaning.
Scale-Up Challenges Remain at the Largest Single-Use Volumes.Scale-up challenges remain at the largest single-use volumes, as agitation hydrodynamics and oxygen transfer characteristics differ between single-use and stainless-steel systems at comparable scale. Process development must account for these differences during technology transfer.
For related market intelligence, see the Biologics Cdmo Market.
8. Segmental Analysis
By type, the stirred tank single-use segment dominated the Single Use Bioreactor Market in 2025, as stirred single-use tanks provide the most scalable and widely adopted format for mammalian cell culture.
By application, the viral vector segment is projected to register the highest CAGR in the Single Use Bioreactor Market through 2034, as gene therapy AAV and lentiviral vector production drives specialised single-use adoption, driving the fastest-growing application category within the market.
9. Regional Analysis
Regional demand patterns across the Single Use Bioreactor Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Single Use Bioreactor Market in 2025, accounting for the largest share of revenue. Moreover, the United States leads through the highest density of biopharmaceutical manufacturing and CDMO operations, the most advanced cell and gene therapy manufacturing programmes using single-use systems, and the primary purchasing decisions of large biopharmaceutical companies with major US operations. In addition, Cytiva and Sartorius serve domestic clients from established sales and service organisations.
Highest CAGR Region
Europe is projected to register the highest CAGR in the Single Use Bioreactor Market through 2034. The primary driver is European CDMO capacity expansion for biologic and gene therapy manufacturing, with Lonza, Fujifilm Diosynth, and Rentschler investing in single-use bioreactor capacity to serve growing client demand. Moreover, European regulatory framework and manufacturing quality system development add institutional demand. The combination of these demand drivers and an expanding base positions Europe for sustained growth outperformance through 2034.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Single Use Bioreactor Market was valued at USD 4.25 Bn in 2025 and is projected to reach USD 14.71 Bn by 2034, growing at a CAGR of 14.8% over the 2026–2034 forecast period.
The Single Use Bioreactor Market is projected to grow at a CAGR of 14.8% from 2026 to 2034.
North America dominated the Single Use Bioreactor Market in 2025, accounting for the largest share of revenue.
The leading companies in the Single Use Bioreactor Market include Cytiva (Danaher), Sartorius, Thermo Fisher Scientific, Merck KGaA (Millipore Sigma), PBS Biotech, ABEC, Pall Corporation (Danaher), Repligen, Eppendorf, Parker Hannifin.
Single-use bioreactors have become the standard for clinical-stage and cdmo manufacturing.
By type, the stirred tank single-use segment dominated the Single Use Bioreactor Market in 2025, as stirred single-use tanks provide the most scalable and widely adopted format for mammalian cell culture.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 3 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 3 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 3 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.